Medical condition
Menopause
Menopause is a medical condition tracked by NovaPharmaNews across 2 associated drugs and ongoing industry coverage. Explore approved and pipeline therapies, regulatory status, and the latest developments.
Associated drugs & therapies
- testosterone (ANDROFORTE 5) Genito-urinary system and sex hormones (G03)
- fezolinetant (VEOZA) Genito-urinary system and sex hormones (G02)
Latest Menopause news
The Perimenopause Movement: A Double-Edged Sword for Women
This article examines the perimenopause movement's impact on women's health and its implications for the pharmaceutical industry.
The Rise of Perimenopause Misinformation: Implications for Pharma
This article examines the growing misinformation surrounding perimenopause and its potential impact on pharmaceutical strategies. Understanding these dynamics is crucial for industry stakeholders.
Vistagen Receives FDA Approval to Advance Refisolone Phase 2 Trial for Menopause Hot Flashes
Vistagen gets FDA clearance to proceed with Phase 2 clinical development of Refisolone, an intranasal treatment for vasomotor symptoms in menopause.
FDA Approves Veozah: New Non-Hormonal Menopause Treatment
Veozah, recently approved by the FDA, provides a non-hormonal option for managing menopause symptoms, marking a significant advancement in women's health.